πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9084820

Magnetic microstructures for magnetic resonance imaging

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9084783

Thio compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9074185

Adoptive cell therapy with young T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9066948

Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056891

Synthetic peptide inhibitors of Wnt pathway

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056907

Human domain antibodies against components of the human insulin-like growth factor (IGF) s

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9056068

Vaccine and methods of use against Strongyloide stercoralis infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9044509

Inhibition of HIV infection through chemoprophylaxis

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9044451

Use of delta tocopherol for the treatment of lysosomal storage disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9034343

Attenuated human parainfluenza virus, methods and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9029344

Linked purine pterin HPPK inhibitors useful as antibacterial agents

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9018371

Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositio

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9018227

Nicotinic acetylcholine receptor agonists

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9012647

Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treat

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9012223

Methods for enhancing genome stability and telomere elongation in embryonic stem cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8999336

Monoclonal antibodies against Orthopoxviruses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8999290

Papillomavirus pseudoviruses for detection and therapy of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8992943

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8993768

Tropolone compounds for treating or preventing retroviral infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8993626

Methods of treatment using sterculic acid

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8987426

Immunotoxin fusion proteins and means for expression thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8980859

Aegyptin and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8980871

Methods of treatment for hemolysis

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8968719

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted